{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T17:14:05Z","timestamp":1774199645691,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1304-2","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T12:18:13Z","timestamp":1495714693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Tie2 as a novel key factor of microangiopathy in systemic sclerosis"],"prefix":"10.1186","volume":"19","author":[{"given":"Falk","family":"Moritz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Schniering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg H. W.","family":"Distler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate E.","family":"Gay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Gay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Distler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,25]]},"reference":[{"issue":"10","key":"1304_CR1","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1136\/annrheumdis-2013-203535","volume":"73","author":"B Maurer","year":"2014","unstructured":"Maurer B, Distler A, Suliman YA, Gay RE, Michel BA, Gay S, Distler JH, Distler O. Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis. Ann Rheum Dis. 2014;73(10):1880\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1304_CR2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","volume":"95","author":"O Distler","year":"2004","unstructured":"Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J, Michel BA, Gay RE, Muller-Ladner U, Matucci-Cerinic M, et al. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res. 2004;95(1):109\u201316.","journal-title":"Circ Res"},{"issue":"6","key":"1304_CR3","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar596","volume":"4","author":"O Distler","year":"2002","unstructured":"Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S, Gay RE, Michel BA, Bruhlmann P, Muller-Ladner U, et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res. 2002;4(6):R11.","journal-title":"Arthritis Res"},{"issue":"12","key":"1304_CR4","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1002\/art.23074","volume":"56","author":"JH Distler","year":"2007","unstructured":"Distler JH, Jungel A, Pileckyte M, Zwerina J, Michel BA, Gay RE, Kowal-Bielecka O, Matucci-Cerinic M, Schett G, Marti HH, et al. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis. Arthritis Rheum. 2007;56(12):4203\u201315.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 3","key":"1304_CR5","first-page":"iii26","volume":"45","author":"JH Distler","year":"2006","unstructured":"Distler JH, Gay S, Distler O. Angiogenesis and vasculogenesis in systemic sclerosis. Rheumatology. 2006;45 Suppl 3:iii26\u201327.","journal-title":"Rheumatology"},{"issue":"2","key":"1304_CR6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10456-009-9147-3","volume":"12","author":"M Thomas","year":"2009","unstructured":"Thomas M, Augustin HG. The role of the Angiopoietins in vascular morphogenesis. Angiogenesis. 2009;12(2):125\u201337.","journal-title":"Angiogenesis"},{"issue":"1-2","key":"1304_CR7","doi-asserted-by":"crossref","first-page":"e957508","DOI":"10.4161\/21688362.2014.957508","volume":"3","author":"KE Milam","year":"2015","unstructured":"Milam KE, Parikh SM. The angiopoietin-Tie2 signaling axis in the vascular leakage of systemic inflammation. Tissue Barriers. 2015;3(1-2):e957508.","journal-title":"Tissue Barriers"},{"key":"1304_CR8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/nyas.12726","volume":"1347","author":"A Scholz","year":"2015","unstructured":"Scholz A, Plate KH, Reiss Y. Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation. Ann N Y Acad Sci. 2015;1347:45\u201351.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"1304_CR9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1172\/JCI0214105","volume":"109","author":"P Vajkoczy","year":"2002","unstructured":"Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest. 2002;109(6):777\u201385.","journal-title":"J Clin Invest"},{"issue":"Pt 4","key":"1304_CR10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1242\/jcs.01653","volume":"118","author":"M Scharpfenecker","year":"2005","unstructured":"Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci. 2005;118(Pt 4):771\u201380.","journal-title":"J Cell Sci"},{"issue":"5322","key":"1304_CR11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","volume":"277","author":"PC Maisonpierre","year":"1997","unstructured":"Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997;277(5322):55\u201360.","journal-title":"Science"},{"issue":"5","key":"1304_CR12","first-page":"2145","volume":"61","author":"T Etoh","year":"2001","unstructured":"Etoh T, Inoue H, Tanaka S, Barnard GF, Kitano S, Mori M. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res. 2001;61(5):2145\u201353.","journal-title":"Cancer Res"},{"issue":"12","key":"1304_CR13","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/ATVBAHA.107.150482","volume":"27","author":"CM Findley","year":"2007","unstructured":"Findley CM, Cudmore MJ, Ahmed A, Kontos CD. VEGF induces Tie2 shedding via a phosphoinositide 3-kinase\/Akt dependent pathway to modulate Tie2 signaling. Arterioscler Thromb Vasc Biol. 2007;27(12):2619\u201326.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"1304_CR14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1012226627813","volume":"4","author":"P Reusch","year":"2001","unstructured":"Reusch P, Barleon B, Weindel K, Martiny-Baron G, Godde A, Siemeister G, Marme D. Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood. Angiogenesis. 2001;4(2):123\u201331.","journal-title":"Angiogenesis"},{"issue":"3","key":"1304_CR15","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1582-4934.2008.00254.x","volume":"12","author":"T Makinde","year":"2008","unstructured":"Makinde T, Agrawal DK. Intra and extravascular transmembrane signalling of angiopoietin-1-Tie2 receptor in health and disease. J Cell Mol Med. 2008;12(3):810\u201328.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"1304_CR16","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/rheumatology\/keq392","volume":"50","author":"M Michalska-Jakubus","year":"2011","unstructured":"Michalska-Jakubus M, Kowal-Bielecka O, Chodorowska G, Bielecki M, Krasowska D. Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease. Rheumatology (Oxford). 2011;50(4):746\u201355.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"1304_CR17","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/j.1468-3083.2011.04012.x","volume":"25","author":"S Noda","year":"2011","unstructured":"Noda S, Asano Y, Aozasa N, Akamata K, Yamada D, Masui Y, Tamaki Z, Kadono T, Sato S. Serum Tie2 levels: clinical association with microangiopathies in patients with systemic sclerosis. J Eur Acad Dermatol Venereol. 2011;25(12):1476\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"1304_CR18","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/MCB.01472-08","volume":"29","author":"HT Yuan","year":"2009","unstructured":"Yuan HT, Khankin EV, Karumanchi SA, Parikh SM. Angiopoietin 2 is a partial agonist\/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol. 2009;29(8):2011\u201322.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"1304_CR19","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger Jr TA, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202\u20135.","journal-title":"J Rheumatol"},{"issue":"1","key":"1304_CR20","first-page":"155","volume":"27","author":"M Cutolo","year":"2000","unstructured":"Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol. 2000;27(1):155\u201360.","journal-title":"J Rheumatol"},{"issue":"1","key":"1304_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1523-1747.1998.00262.x","volume":"111","author":"M Detmar","year":"1998","unstructured":"Detmar M, Brown LF, Schon MP, Elicker BM, Velasco P, Richard L, Fukumura D, Monsky W, Claffey KP, Jain RK. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol. 1998;111(1):1\u20136.","journal-title":"J Invest Dermatol"},{"key":"1304_CR22","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1096\/fj.07-105627","volume":"22","author":"ADC Akhmetshina","year":"2008","unstructured":"Akhmetshina ADC, Pileckyte M, Maurer B, Axmann R, J\u00fcngel A, Zwerina J, Gay S, Schett G, Distler O, Distler JH. Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis. FASEB J. 2008;22:2214\u201322.","journal-title":"FASEB J"},{"key":"1304_CR23","doi-asserted-by":"crossref","unstructured":"Siracusa LD, McGrath R, Ma Q, Moskow JJ, Manne J, Christner PJ, Buchberg AM, Jimenez SA. A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res. 1996;6(4):300\u201313.","DOI":"10.1101\/gr.6.4.300"},{"key":"1304_CR24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.22314","volume":"56","author":"JHJA Distler","year":"2007","unstructured":"Distler JHJA, Huber LC, Schulze-Horsel U, Zwerina J, Gay RE, Michel BA, Hauser T, Schett G, Gay S, Distler O. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis Rheum. 2007;56:311\u201322.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1304_CR25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.22314","volume":"56","author":"JH Distler","year":"2007","unstructured":"Distler JH, Jungel A, Huber LC, Schulze-Horsel U, Zwerina J, Gay RE, Michel BA, Hauser T, Schett G, Gay S, et al. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis Rheum. 2007;56(1):311\u201322.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1304_CR26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1083\/jcb.200608093","volume":"177","author":"SG Ball","year":"2007","unstructured":"Ball SG, Shuttleworth CA, Kielty CM. Vascular endothelial growth factor can signal through platelet-derived growth factor receptors. J Cell Biol. 2007;177(3):489\u2013500.","journal-title":"J Cell Biol"},{"issue":"12","key":"1304_CR27","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/ATVBAHA.107.150482","volume":"27","author":"CM Findley","year":"2007","unstructured":"Findley CM, Cudmore MJ, Ahmed A, Kontos CD. VEGF induces Tie2 shedding via a phosphoinositide 3-kinase\/Akt-dependent pathway to modulate Tie2 signaling. Arterioscler Thromb Vasc Biol. 2007;27(12):2619\u201326.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1304_CR28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/art.24186","volume":"60","author":"A Akhmetshina","year":"2009","unstructured":"Akhmetshina A, Venalis P, Dees C, Busch N, Zwerina J, Schett G, Distler O, Distler JH. Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis. Arthritis Rheum. 2009;60(1):219\u201324.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1304_CR29","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1002\/art.27647","volume":"62","author":"C Beyer","year":"2010","unstructured":"Beyer C, Schett G, Distler O, Distler JH. Animal models of systemic sclerosis: prospects and limitations. Arthritis Rheum. 2010;62(10):2831\u201344.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1304_CR30","first-page":"493","volume":"82","author":"MC Green","year":"1976","unstructured":"Green MC, Sweet HO, Bunker LE. Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton. Am J Pathol. 1976;82(3):493\u2013512.","journal-title":"Am J Pathol"},{"issue":"2 Suppl 65","key":"1304_CR31","first-page":"S46","volume":"29","author":"V Riccieri","year":"2011","unstructured":"Riccieri V, Stefanantoni K, Vasile M, Macri V, Sciarra I, Iannace N, Alessandri C, Valesini G. Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis. Clin Exp Rheumatol. 2011;29(2 Suppl 65):S46\u201352.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"1304_CR32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00296-012-2378-4","volume":"33","author":"JV Dunne","year":"2013","unstructured":"Dunne JV, Keen KJ, Van Eeden SF. Circulating angiopoietin and Tie-2 levels in systemic sclerosis. Rheumatol Int. 2013;33(2):475\u201384.","journal-title":"Rheumatol Int"},{"issue":"3","key":"1304_CR33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000357806","volume":"228","author":"Z Gerlicz","year":"2014","unstructured":"Gerlicz Z, Dziankowska-Bartkowiak B, Dziankowska-Zaborszczyk E, Sysa-Jedrzejowska A. Disturbed balance between serum levels of receptor tyrosine kinases Tie-1, Tie-2 and angiopoietins in systemic sclerosis. Dermatology. 2014;228(3):233\u20139.","journal-title":"Dermatology"},{"issue":"3","key":"1304_CR34","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","volume":"109","author":"M Manetti","year":"2011","unstructured":"Manetti M, Guiducci S, Romano E, Ceccarelli C, Bellando-Randone S, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis. Circ Res. 2011;109(3):e14\u201326.","journal-title":"Circ Res"},{"issue":"12","key":"1304_CR35","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1136\/annrheumdis-2013-203729","volume":"72","author":"B Maurer","year":"2013","unstructured":"Maurer B, Distler A, Dees C, Khan K, Denton CP, Abraham D, Gay RE, Michel BA, Gay S, Hw Distler J, et al. Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitors. Ann Rheum Dis. 2013;72(12):2039\u201346.","journal-title":"Ann Rheum Dis"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1304-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T12:18:27Z","timestamp":1495714707000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1304-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,25]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1304"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1304-2","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,25]]},"article-number":"105"}}